All News

Gordon Bernard, MD, right, with Jeff Balser, MD, PhD, and Jennifer Pietenpol, PhD. (p(photo by Erin O. Smith)

Reception honors Gordon Bernard’s decades of service and contributions

Gordon Bernard, MD, was honored at a reception on July 19 in recognition of his contributions to Vanderbilt University Medical Center for more than 40 years.

Predicting gene expression may speed discovery: study

Researchers at Vanderbilt University Medical Center and the University of Cambridge have developed a method of or predicting gene expression in hard-to-access tissues like the brain from more accessible tissues, including whole blood.

Rare case: brain injury stirs creativity, synesthesia

Vanderbilt researchers report on a musician who acquired synesthesia — a merging of sensations — and improved creativity following a traumatic brain injury.

Aspirnaut student Nayla Ramos Vega, 15, wants to be a neurosurgeon.

Summer program gives high schoolers taste of discovery

Since the Aspirnaut high school summer research internship program was launched in 2009, 334 students from 34 states have participated. To date, nearly 90 of them have gone to earn MD degrees, PhDs, or both.

Holowatyj receives National Cancer Institute MERIT Award

Vanderbilt’s Andreana Holowatyj, PhD, MSCI, has received the National Cancer Institute’s Method to Extend Research in Time Award to support her ongoing investigation into how early-onset colorectal cancer and its treatments impact reproductive health.

The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer and Merck

Illumina Inc., in collaboration with Nashville Biosciences LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, have announced the five founding new members of the Alliance for Genomic Discovery.

1 104 105 106 107 108 151